Listed

Adaptive Biotechnologies Corp

ADPTNasdaqCIK 1478320HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$71.6m, Q2 FY2026
Operating income−$15.8m, Q2 FY2026
Net income−$39.8m, Q2 FY2026
Adaptive Biotechnologies Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m37.9Revenue, Q3 FY2023, three months to 2023-09-30$37.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure45.8Revenue, Q4 FY2023, three months to 2023-12-31$45.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure41.9Revenue, Q1 FY2024, three months to 2024-03-31$41.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure43.2Revenue, Q2 FY2024, three months to 2024-06-30$43.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure46.4Revenue, Q3 FY2024, three months to 2024-09-30$46.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure47.5Revenue, Q4 FY2024, three months to 2024-12-31$47.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure52.4Revenue, Q1 FY2025, three months to 2025-03-31$52.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure58.9Revenue, Q2 FY2025, three months to 2025-06-30$58.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure94.0Revenue, Q3 FY2025, three months to 2025-09-30$94.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure71.7Revenue, Q4 FY2025, three months to 2025-12-31$71.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure70.9Revenue, Q1 FY2026, three months to 2026-03-31$70.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure71.6Revenue, Q2 FY2026, three months to 2026-06-30$71.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Cost of revenue$m19.3Cost of revenue, Q3 FY2023, three months to 2023-09-30$19.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure19.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$19.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure18.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$18.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure19.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$19.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure16.7Cost of revenue, Q3 FY2024, three months to 2024-09-30$16.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure18.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$18.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure17.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$17.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure18.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$18.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure18.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$18.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure18.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$18.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure18.7Cost of revenue, Q1 FY2026, three months to 2026-03-31$18.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure20.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$20.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Research and development$m28.5Research and development, Q3 FY2023, three months to 2023-09-30$28.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure28.7Research and development, Q4 FY2023, three months to 2023-12-31$28.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure30.2Research and development, Q1 FY2024, three months to 2024-03-31$30.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure25.4Research and development, Q2 FY2024, three months to 2024-06-30$25.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure24.2Research and development, Q3 FY2024, three months to 2024-09-30$24.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure23.2Research and development, Q4 FY2024, three months to 2024-12-31$23.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure24.2Research and development, Q1 FY2025, three months to 2025-03-31$24.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure24.1Research and development, Q2 FY2025, three months to 2025-06-30$24.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure23.7Research and development, Q3 FY2025, three months to 2025-09-30$23.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure21.8Research and development, Q4 FY2025, three months to 2025-12-31$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure23.6Research and development, Q1 FY2026, three months to 2026-03-31$23.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure19.2Research and development, Q2 FY2026, three months to 2026-06-30$19.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Operating income$m(51.0)Operating income, Q3 FY2023, three months to 2023-09-30−$51.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure(71.1)Operating income, Q4 FY2023, three months to 2023-12-31−$71.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(48.8)Operating income, Q1 FY2024, three months to 2024-03-31−$48.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure(47.3)Operating income, Q2 FY2024, three months to 2024-06-30−$47.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure(32.6)Operating income, Q3 FY2024, three months to 2024-09-30−$32.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure(33.8)Operating income, Q4 FY2024, three months to 2024-12-31−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(29.6)Operating income, Q1 FY2025, three months to 2025-03-31−$29.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(25.0)Operating income, Q2 FY2025, three months to 2025-06-30−$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure10.3Operating income, Q3 FY2025, three months to 2025-09-30$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure(12.8)Operating income, Q4 FY2025, three months to 2025-12-31−$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(19.2)Operating income, Q1 FY2026, three months to 2026-03-31−$19.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(15.8)Operating income, Q2 FY2026, three months to 2026-06-30−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Interest expense$m3.7Interest expense, Q3 FY2023, three months to 2023-09-30$3.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure3.0Interest expense, Q4 FY2023, three months to 2023-12-31$3.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2024, three months to 2024-03-31$3.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure2.7Interest expense, Q2 FY2024, three months to 2024-06-30$2.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure2.9Interest expense, Q3 FY2024, three months to 2024-09-30$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure3.0Interest expense, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure2.9Interest expense, Q1 FY2025, three months to 2025-03-31$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure2.9Interest expense, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure3.0Interest expense, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure3.0Interest expense, Q4 FY2025, three months to 2025-12-31$3.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure2.9Interest expense, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure2.7Interest expense, Q2 FY2026, three months to 2026-06-30$2.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(50.3)Net income, Q3 FY2023, three months to 2023-09-30−$50.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure(69.4)Net income, Q4 FY2023, three months to 2023-12-31−$69.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(47.5)Net income, Q1 FY2024, three months to 2024-03-31−$47.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure(46.2)Net income, Q2 FY2024, three months to 2024-06-30−$46.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure(32.1)Net income, Q3 FY2024, three months to 2024-09-30−$32.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure(33.7)Net income, Q4 FY2024, three months to 2024-12-31−$33.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(29.9)Net income, Q1 FY2025, three months to 2025-03-31−$29.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(25.6)Net income, Q2 FY2025, three months to 2025-06-30−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure9.5Net income, Q3 FY2025, three months to 2025-09-30$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure(13.6)Net income, Q4 FY2025, three months to 2025-12-31−$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(20.0)Net income, Q1 FY2026, three months to 2026-03-31−$20.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(39.8)Net income, Q2 FY2026, three months to 2026-06-30−$39.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Diluted EPS$ per share(0.35)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figurenot reported(0.33)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure(0.31)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(0.17)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure0.06Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figurenot reported(0.13)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(0.25)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Basic EPS$ per share(0.35)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figurenot reported(0.33)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure(0.31)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure(0.22)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figurenot reported(0.20)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(0.17)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure0.06Basic EPS, Q3 FY2025, three months to 2025-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figurenot reported(0.13)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(0.25)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure

Balance sheet

Cash and equivalents$169.9m, Q2 FY2026
Long-term debt$0, Q2 FY2026
Shareholders' equity$142.9m, Q2 FY2026
Adaptive Biotechnologies Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m88.7Cash and equivalents, Q3 FY2023, at 2023-09-30$88.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure65.1Cash and equivalents, FY2023, at 2023-12-31$65.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure71.2Cash and equivalents, Q1 FY2024, at 2024-03-31$71.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure59.8Cash and equivalents, Q2 FY2024, at 2024-06-30$59.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure38.1Cash and equivalents, Q3 FY2024, at 2024-09-30$38.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure47.9Cash and equivalents, FY2024, at 2024-12-31$47.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure50.6Cash and equivalents, Q1 FY2025, at 2025-03-31$50.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure43.2Cash and equivalents, Q2 FY2025, at 2025-06-30$43.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure55.0Cash and equivalents, Q3 FY2025, at 2025-09-30$55.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure70.5Cash and equivalents, FY2025, at 2025-12-31$70.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure77.6Cash and equivalents, Q1 FY2026, at 2026-03-31$77.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure170Cash and equivalents, Q2 FY2026, at 2026-06-30$169.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Current assets$m435Current assets, Q3 FY2023, at 2023-09-30$435.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure410Current assets, FY2023, at 2023-12-31$410.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure374Current assets, Q1 FY2024, at 2024-03-31$374.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure352Current assets, Q2 FY2024, at 2024-06-30$351.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure308Current assets, Q3 FY2024, at 2024-09-30$308.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure284Current assets, FY2024, at 2024-12-31$283.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure256Current assets, Q1 FY2025, at 2025-03-31$256.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure262Current assets, Q2 FY2025, at 2025-06-30$261.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure281Current assets, Q3 FY2025, at 2025-09-30$281.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure300Current assets, FY2025, at 2025-12-31$300.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure292Current assets, Q1 FY2026, at 2026-03-31$291.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure421Current assets, Q2 FY2026, at 2026-06-30$420.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Total assets$m718Total assets, Q3 FY2023, at 2023-09-30$717.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure661Total assets, FY2023, at 2023-12-31$661.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure620Total assets, Q1 FY2024, at 2024-03-31$620.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure585Total assets, Q2 FY2024, at 2024-06-30$584.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure559Total assets, Q3 FY2024, at 2024-09-30$558.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure539Total assets, FY2024, at 2024-12-31$539.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure511Total assets, Q1 FY2025, at 2025-03-31$510.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure497Total assets, Q2 FY2025, at 2025-06-30$496.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure491Total assets, Q3 FY2025, at 2025-09-30$490.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure513Total assets, FY2025, at 2025-12-31$512.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure506Total assets, Q1 FY2026, at 2026-03-31$505.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure641Total assets, Q2 FY2026, at 2026-06-30$640.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Current liabilities$m93.3Current liabilities, Q3 FY2023, at 2023-09-30$93.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure88.0Current liabilities, FY2023, at 2023-12-31$88.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure83.0Current liabilities, Q1 FY2024, at 2024-03-31$83.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure88.1Current liabilities, Q2 FY2024, at 2024-06-30$88.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure87.6Current liabilities, Q3 FY2024, at 2024-09-30$87.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure98.1Current liabilities, FY2024, at 2024-12-31$98.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure87.8Current liabilities, Q1 FY2025, at 2025-03-31$87.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure92.1Current liabilities, Q2 FY2025, at 2025-06-30$92.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure83.4Current liabilities, Q3 FY2025, at 2025-09-30$83.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure89.9Current liabilities, FY2025, at 2025-12-31$89.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure87.0Current liabilities, Q1 FY2026, at 2026-03-31$87.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure87.7Current liabilities, Q2 FY2026, at 2026-06-30$87.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Total liabilities$m356Total liabilities, Q3 FY2023, at 2023-09-30$356.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure353Total liabilities, FY2023, at 2023-12-31$352.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure346Total liabilities, Q1 FY2024, at 2024-03-31$345.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure343Total liabilities, Q2 FY2024, at 2024-06-30$343.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure335Total liabilities, Q3 FY2024, at 2024-09-30$334.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure337Total liabilities, FY2024, at 2024-12-31$336.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure321Total liabilities, Q1 FY2025, at 2025-03-31$320.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure317Total liabilities, Q2 FY2025, at 2025-06-30$317.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure286Total liabilities, Q3 FY2025, at 2025-09-30$286.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure288Total liabilities, FY2025, at 2025-12-31$287.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure282Total liabilities, Q1 FY2026, at 2026-03-31$281.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure490Total liabilities, Q2 FY2026, at 2026-06-30$490.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Long-term debt$m127Long-term debt, Q3 FY2023, at 2023-09-30$126.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure131Long-term debt, FY2023, at 2023-12-31$130.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure132Long-term debt, Q1 FY2024, at 2024-03-31$131.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure132Long-term debt, Q2 FY2024, at 2024-06-30$132.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure133Long-term debt, Q3 FY2024, at 2024-09-30$132.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure132Long-term debt, FY2024, at 2024-12-31$132.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure132Long-term debt, Q1 FY2025, at 2025-03-31$131.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure130Long-term debt, Q2 FY2025, at 2025-06-30$130.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure129Long-term debt, Q3 FY2025, at 2025-09-30$129.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure127Long-term debt, FY2025, at 2025-12-31$126.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure125Long-term debt, Q1 FY2026, at 2026-03-31$124.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure0.0Long-term debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Current portion of debt$m3.2Current portion of debt, Q3 FY2023, at 2023-09-30$3.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figurenot reportednot reportednot reportednot reported0.9Current portion of debt, FY2024, at 2024-12-31$865.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure2.0Current portion of debt, Q1 FY2025, at 2025-03-31$2.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure3.1Current portion of debt, Q2 FY2025, at 2025-06-30$3.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure2.4Current portion of debt, Q3 FY2025, at 2025-09-30$2.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure4.6Current portion of debt, FY2025, at 2025-12-31$4.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure5.8Current portion of debt, Q1 FY2026, at 2026-03-31$5.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure0.0Current portion of debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure
Shareholders' equity$m362Shareholders' equity, Q3 FY2023, at 2023-09-30$361.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure308Shareholders' equity, FY2023, at 2023-12-31$308.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-03, accession 0000950170-25-030913.Report this figure275Shareholders' equity, Q1 FY2024, at 2024-03-31$274.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure242Shareholders' equity, Q2 FY2024, at 2024-06-30$241.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure224Shareholders' equity, Q3 FY2024, at 2024-09-30$223.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure203Shareholders' equity, FY2024, at 2024-12-31$202.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076902.Report this figure190Shareholders' equity, Q1 FY2025, at 2025-03-31$190.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure180Shareholders' equity, Q2 FY2025, at 2025-06-30$179.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure204Shareholders' equity, Q3 FY2025, at 2025-09-30$204.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure219Shareholders' equity, FY2025, at 2025-12-31$218.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure216Shareholders' equity, Q1 FY2026, at 2026-03-31$216.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure143Shareholders' equity, Q2 FY2026, at 2026-06-30$142.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure

Cash flow

Operating cash flow−$6.4m, Q2 FY2026
Capital expenditure$1.2m, Q2 FY2026
Adaptive Biotechnologies Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(46.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$46.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123423. Derived: 9-month figure less the 6-month figure.Report this figure(26.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$26.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(38.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$38.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure(17.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000950170-25-103120. Derived: 6-month figure less the 3-month figure.Report this figure(27.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$27.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-267061. Derived: 9-month figure less the 6-month figure.Report this figure(12.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(28.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$28.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(12.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332940. Derived: 6-month figure less the 3-month figure.Report this figure(7.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-267061. Derived: 9-month figure less the 6-month figure.Report this figure2.1Operating cash flow, Q4 FY2025, three months to 2025-12-31$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure(6.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332940. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m2.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123423. Derived: 9-month figure less the 6-month figure.Report this figure1.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure1.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure1.7Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000950170-25-103120. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$344.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-267061. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$80.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure1.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure0.7Capital expenditure, Q2 FY2025, three months to 2025-06-30$655.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332940. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$409.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-267061. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$636.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076902. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$796.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure1.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332940. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)159.86m, Q2 FY2026
Adaptive Biotechnologies Corp, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares143Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30142,928,654 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062136.Report this figure144Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31143,511,142 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-054604.Report this figure144Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30144,397,693 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0000950170-24-089342.Report this figure145Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30144,704,868 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123423.Report this figure146Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31145,787,527 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0000950170-25-061897.Report this figure147Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30147,414,095 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000950170-25-103120.Report this figure148Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30147,516,398 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure149Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31149,195,028 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure152Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30152,082,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure163Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30163,162,107 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-267061.Report this figure156Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31155,521,048 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206546.Report this figure160Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30159,855,257 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure

Shares outstanding: 159.60mShares outstanding, period not labelled, at 2026-07-31159,595,842 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332940.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.